Vimarsana
Biggest News Aggregation in the World

Type Multi Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Type Multi Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Type Multi Test Today - Breaking & Trending Today

Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial - Vimarsana News

Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial

Published: October 30, 2023

MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, is pleased to provide an update on the company activities for the quarter ending 30 September 2023. Highlights: Partnership signed with the Gold Coast Private Hospital (a member of Healthscope), to establish a Precision Medicine Clinic at the hospital.GeneType Multi-Test

Source: yahoo.com
Related Topics:
Richard AllmanJon EmerySimon MorrissNicholas MurphyAdrian MulcahyErika SpaethChi Kuen WongGenetic Technologies LimitedGenomics Health Futures Mission GrantWorld Economic ForumPrecision Medicine Pilot PartnershipGenetic TechnologiesCenters For Medicare MedicaidNational Association Of Testing AuthorityResearch Future FundAustralian Institute Of HealthTechnologies LimitedGold Coast Private HospitalPrecision Medicine ClinicType Multi TestPancreatic CancerAtrial FibrillationChief Executive Officer Simon MorrissAchievements DuringMedicine Pilot Partnership
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial - Genetic Technologies (NASDAQ:GENE) - Vimarsana News

Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial - Genetic Technologies (NASDAQ:GENE)

Published: October 30, 2023

MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in guideline-driven genomics-based testing in health, wellness and

Source: benzinga.com
Related Topics:
Adrian MulcahySimon MorrissErika SpaethChi Kuen WongJon EmeryRichard AllmanNicholas MurphyGenetic TechnologiesPrecision Medicine Pilot PartnershipGenomics Health Futures Mission GrantWorld Economic ForumGenetic Technologies LimitedCenters For Medicare MedicaidAustralian Institute Of HealthResearch Future FundNational Association Of Testing AuthorityTechnologies LimitedGold Coast Private HospitalPrecision Medicine ClinicType Multi TestPancreatic CancerAtrial FibrillationChief Executive Officer Simon MorrissAchievements DuringMedicine Pilot Partnership
GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network - Vimarsana News

GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network

Published: September 27, 2023

MELBOURNE, Australia, Sept. 27, 2023 -- Genetic Technologies Limited – a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce a partnership with...

Source: marketscreener.com
Related Topics:
Gold CoastAdrian MulcahyMichelle Ferrari CestariDrug AdministrationGenetic TechnologiesGenetic Technologies LimitedTechnologies LimitedGold Coast Private HospitalPrecision Medicine ClinicType Multi RiskPrecision Medicine ClinicsCoast Private HospitalPrecision MedicineType Multi Test
Genetic Technologies : Genetype and Gold Coast Private Hospital Announce Precision Medicine Pilot - Form 6-K -September 27, 2023 at 08:03 am EDT - Vimarsana News

Genetic Technologies : Genetype and Gold Coast Private Hospital Announce Precision Medicine Pilot - Form 6-K -September 27, 2023 at 08:03 am EDT

Published: September 27, 2023

A global leader in genomics-based tests in health, wellness and serious disease is pleased to announce a partnership with the Gold Coast Private Hospital , a member of Healthscope, to establish a...

Source: marketscreener.com
Related Topics:
Gold CoastMichelle Ferrari CestariAdrian MulcahyDrug AdministrationGenetic TechnologiesGenetic Technologies LimitedExchange CommissionGold Coast Private HospitalPrecision Medicine ClinicType Multi RiskPrecision Medicine ClinicsCoast Private HospitalPrecision MedicineType Multi TestSimon MorrissTechnologies Limited
GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation - Vimarsana News

GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation

Published: March 27, 2023

MELBOURNE, Australia, March 27, 2023 -- Genetic Technologies Limited – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce the US... | March 27, 2023

Source: marketscreener.com
Related Topics:
United StatesSimon MorrissGenetic TechnologiesAmerican Cancer SocietyExchange CommissionGenetic Technologies LimitedCenters For Disease ControlTechnologies LimitedType Multi TestType MultiPancreatic CancerAtrial FibrillationGenetype Multi TestDisease ControlGenetic Technologies Limited Stock ExchangePress ReleaseHe Gtg Au000000gtg7